Delhi's Supreme Court ruling declares walking on footpaths a fundamental right, yet citizens face daily struggles with damaged, missing, or...

Alembic Pharmaceuticals has secured USFDA approval for its generic oseltamivir phosphate oral suspension, a key treatment for influenza. Th...

Indian pharmaceutical giant Lupin Ltd has secured tentative approval from the US FDA for its generic enzalutamide tablets, a crucial treatm...

India is set to implement a mandatory registration for printed pharmaceutical packaging manufacturers to combat counterfeit drugs. This mov...

A BJP councillor from East Delhi, Shashi Chandna, suffered severe injuries after being attacked by stray cattle on Wednesday. While returni...

Indian contract manufacturers are poised for significant growth as global pharmaceutical giants diversify away from China. Companies like S...

A significant fire at a New Delhi data centre, a joint venture between ST Telemedia and Tata Communications, has caused extensive damage, c...

Chinese Foreign Minister Wang Yi met with Prime Minister Narendra Modi in New Delhi, expressing readiness to work with India on sensitive i...

A man will receive Rs 4,000 in compensation after an e-commerce company failed to deliver his grandmother's birthday cake, despite charging...

Mamaearth's parent company, Honasa Consumer, is acquiring a majority stake in nutraceuticals brand Fluence Pharma for ₹135 crore. This stra...

Niti Aayog proposes a blueprint for free trade agreements to boost regulatory predictability in India's pharmaceutical sector. The think ta...

Honasa Consumer, parent of Mamaearth, is acquiring a 58% stake in nutraceuticals firm Fluence Pharma for Rs 135 crore, marking its entry in...

India's pharmaceutical sector is pivoting beyond generics, with companies aggressively pursuing growth in biosimilars, nutraceuticals, and ...

Health officials revealed that in May 2026, 46 drug samples tested by Central Drugs Laboratories and 113 by State Drugs Testing Laboratorie...

Indian markets saw a dip on Friday, with IT stocks leading the decline. Analysts suggest profit-taking occurred near the 24,150 mark. Despi...

Jubilant Pharmova announced its US subsidiary, Jubilant HollisterStier LLC, underwent a USFDA inspection. The facility in Spokane, Washingt...

Four new "Namo Cities" will be developed across the NCR with Rs 5,000 crore in central assistance over five years. The existing NCR boundar...